Obermatt

Integer

NYQ:ITGR · US45826H1095
Health Care Equipment & SuppliesLarge

360

26
EV / EBIT12
Price / Owner Earnings45
Owner Earnings Yield74
Dividend Yield1
Price/Sales70
EV / Gross Profit15
Price/Book67
Return on Capital53
Cash Return on Capital63
Return on Equity65
EBIT Margin58
Gross Profitability8
Cash Conversion25
Accruals24
Owner Earnings Margin80
Sales growth8
Profit Growth70
Long-Term EPS Growth47
Owner Earnings Growth89
Reinvestment48
Price momentum43
Debt load36
Refinancing82
Debt Payback23
Liquidity66
Analyst ratings26
Opinion Changes72
Price Target Upside18
Market mood33
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Integer clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1997
Employees2,165
ISINUS45826H1095
Last UpdateApr 2, 2026
Themes
UrologyGastroenterologyCardiovascularNeurologyOrthopaedicsSurgeryOncologyHealth CareManufacturingMedicalMedical Device

Description

Integer Holdings Corporation (Integer) is a medical device contract development and manufacturing organization (CDMO) worldwide. The company is serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. As a strategic p…

Analysis

Middle-of-the-road

Integer Holdings Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is fair. The owner-earnings multiple stands at 16.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 4% a year, against analyst forecasts of 7%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
63
2023202420252026

All-time high

94

Aug 2024

All-time low

63

Jun 2026

Average rank

82

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
70
50
64
79
Price/Earnings
45
44
50
79
Price/Book
67
62
66
80
Dividend Yield
1
1
1
1
Value (overall)
61
49
42
51

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Integer with its peers
Boston Scientific
NYQ:BSX
75
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Edwards Lifesciences
NYQ:EW
55
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Teleflex
NYQ:TFX
5
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Delcath Systems
NAQ:DCTH
34
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Abbott Laboratories
NYQ:ABT
41
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
AngioDynamics
NSQ:ANGO
57
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →